Efforts across the Programs Healthy Longevity Grand Challenge
|Key Fields||Other Programs|
|R&D phase||Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, Clinical Trials, Post Marketing, Clinical Research, None|
The Healthy Longevity Grand Challenge is conceptualized, founded, and coordinated internationally by the NAM in global collaboration with Academia Sinica of Taiwan, Chinese Academy of Medical Sciences, EIT Health (supported by EIT, a body of the European Union), Ministry of Health and National Research Foundation of Singapore, United Kingdom Research and Innovation, U.S. National Academy of Medicine (supported by Johnson & Johnson Innovation), U.S. National Institute on Aging and AMED. It calls on teams and individuals of any background - including biomedical sciences, technology and engineering, social sciences, financing, and beyond - to submit bold, innovative ideas, with the goal of extending the human healthspan. It seeks to amass a diverse portfolio of ideas, focusing on areas such as disease prevention, molecular pathways, mobility, functionality, social connectedness, and more.
In Japan, the AMED will issue up to 60 Catalyst Awards between 2020 and 2022, to researchers that are currently or previously funded by AMED.
Last updated 2020.2.10